These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34097808)

  • 1. Plasma levels do not predict thrombin generation in patients taking direct oral anticoagulants.
    Metze M; Klöter T; Stöbe S; Rechenberger B; Siegemund R; Siegemund T; Laufs U; Petros S; Pfrepper C
    Int J Lab Hematol; 2021 Dec; 43(6):1539-1548. PubMed ID: 34097808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of direct oral anticoagulants on thrombin generation on Ceveron TGA.
    Pfrepper C; Behrendt LC; Bönigk H; Siegemund T; Metze M; Franke D; Petros S; Siegemund A
    Int J Lab Hematol; 2022 Feb; 44(1):193-201. PubMed ID: 34585540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of thrombin generation 12 hours after intake of direct oral anticoagulants.
    Metze M; Pfrepper C; Klöter T; Stöbe S; Siegemund R; Siegemund T; Edel E; Laufs U; Petros S
    Res Pract Thromb Haemost; 2020 May; 4(4):610-618. PubMed ID: 32548560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of direct oral anticoagulants on thrombin generation and fibrinolysis in patients with atrial fibrillation and venous thromboembolism.
    Dirienzo L; Vitulli A; Mancazzo F; Ammollo CT; Dellanoce C; Paoletti O; Testa S; Colucci M
    Blood Transfus; 2022 Nov; 20(6):505-515. PubMed ID: 34967721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct oral anticoagulant plasma levels and thrombin generation on ST Genesia system.
    Pfrepper C; Metze M; Siegemund A; Klöter T; Siegemund T; Petros S
    Res Pract Thromb Haemost; 2020 May; 4(4):619-627. PubMed ID: 32548561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the effect of direct oral anticoagulants dabigatran, rivaroxaban, and apixaban in healthy male volunteers using a thrombin generation assay.
    Artang R; Anderson M; Riley P; Nielsen JD
    Res Pract Thromb Haemost; 2017 Oct; 1(2):194-201. PubMed ID: 30046690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of DOAC Filter, a new device to remove direct oral anticoagulants from plasma samples.
    Sevenet PO; Cucini V; Hervé T; Depasse F; Carlo A; Contant G; Mathieu O
    Int J Lab Hematol; 2020 Oct; 42(5):636-642. PubMed ID: 32567799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis.
    Ebner M; Birschmann I; Peter A; Härtig F; Spencer C; Kuhn J; Rupp A; Blumenstock G; Zuern CS; Ziemann U; Poli S
    J Am Heart Assoc; 2018 Oct; 7(19):e009807. PubMed ID: 30371316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter- and intra-individual concentrations of direct oral anticoagulants: The KIDOAC study.
    Toorop MMA; van Rein N; Nierman MC; Vermaas HW; Huisman MV; van der Meer FJM; Cannegieter SC; Lijfering WM
    J Thromb Haemost; 2022 Jan; 20(1):92-103. PubMed ID: 34664401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of DOAC Stop for elimination of anticoagulants in the thrombin generation assay.
    Kopatz WF; Brinkman HJM; Meijers JCM
    Thromb Res; 2018 Oct; 170():97-101. PubMed ID: 30149286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How the direct oral anticoagulant apixaban affects thrombin generation parameters.
    Tripodi A; Padovan L; Veena C; Scalambrino E; Testa S; Peyvandi F
    Thromb Res; 2015 Jun; 135(6):1186-90. PubMed ID: 25895845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of DOAC in GEriatrics (Adage Study): Rivaroxaban/Apixaban Concentrations and Thrombin Generation Profiles in NVAF Very Elderly Patients.
    Foulon-Pinto G; Lafuente-Lafuente C; Jourdi G; Guen JL; Tall F; Puymirat E; Delrue M; Rivière L; Ketz F; Gouin-Thibault I; Mullier F; Gaussem P; Pautas E; Lecompte T; Curis E; Siguret V
    Thromb Haemost; 2023 Apr; 123(4):402-414. PubMed ID: 36395818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An optimized dRVVT-based assay to estimate the intensity of anticoagulation in patients treated with direct oral anticoagulants.
    Sennesael AL; Exner T; Chatelain B; Lessire S; Larock AS; Vancraeynest C; Pochet L; Dogné JM; Spinewine A; Mullier F; Douxfils J
    Thromb Res; 2017 Sep; 157():29-37. PubMed ID: 28686914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on laboratory assessment for direct oral anticoagulants (DOACs).
    Gosselin RC; Adcock DM; Douxfils J
    Int J Lab Hematol; 2019 May; 41 Suppl 1():33-39. PubMed ID: 31069969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of centrifugation on thrombin generation in healthy subjects and in patients treated with direct oral anticoagulants.
    Hardy M; Dellanoce C; Douxfils J; Carlo A; Lessire S; Bouvy C; Testa S; Mullier F
    Int J Lab Hematol; 2021 Dec; 43(6):1585-1592. PubMed ID: 34252264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians.
    Douxfils J; Ageno W; Samama CM; Lessire S; Ten Cate H; Verhamme P; Dogné JM; Mullier F
    J Thromb Haemost; 2018 Feb; 16(2):209-219. PubMed ID: 29193737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know.
    Conway SE; Hwang AY; Ponte CD; Gums JG
    Pharmacotherapy; 2017 Feb; 37(2):236-248. PubMed ID: 27983747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct oral anticoagulants and heparins: laboratory values and pitfalls in 'bridging therapy'.
    Eller T; Flieder T; Fox V; Gripp T; Dittrich M; Kuhn J; Alban S; Knabbe C; Birschmann I
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):624-632. PubMed ID: 28043992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban Measurements.
    Meihandoest T; Studt JD; Mendez A; Alberio L; Fontana P; Wuillemin WA; Schmidt A; Graf L; Gerber B; Maeder GM; Bovet C; Sauter TC; Nagler M
    Front Cardiovasc Med; 2021; 8():717939. PubMed ID: 34568459
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants.
    Ząbczyk M; Kopytek M; Natorska J; Undas A
    Clin Chem Lab Med; 2019 Aug; 57(9):1374-1381. PubMed ID: 30763261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.